|
101 |
Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
Enthalten in Drugs in R & D Bd. 11, 27.11.2012, Nr. 1, date:3.2011: 1-11
|
|
|
|
102 |
Cetuximab-Associated Elongation of the Eyelashes
Enthalten in American journal of clinical dermatology Bd. 12, 10.9.2012, Nr. 1, date:2.2011: 63-67
|
|
|
|
103 |
Chemotherapy Administration
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1173-1186
|
|
|
|
104 |
Chronic Kidney Disease in the Hypertensive Patient
Enthalten in High blood pressure & cardiovascular prevention Bd. 18, 27.11.2012, Nr. 1, date:3.2011: 31-36
|
|
|
|
105 |
Chronic Obstructive Pulmonary Disease
Enthalten in Drugs & aging Bd. 26, 11.9.2012, Nr. 10, date:10.2009: 813-831
|
|
|
|
106 |
Cladribine Tablets
Enthalten in CNS drugs Bd. 25, 1.3.2011, Nr. 3, date:3.2011: 239-249
|
|
|
|
107 |
Clinical Aspects of Invasive Candidiasis
Enthalten in Drugs Bd. 69, 29.9.2012, Nr. 1, date:11.2009: 39-43
|
|
|
|
108 |
Clinical Aspects of Invasive Candidiasis in Solid Organ Transplant Recipients
Enthalten in Drugs Bd. 69, 29.9.2012, Nr. 1, date:11.2009: 15-20
|
|
|
|
109 |
Clinical Aspects of Invasive Candidiasis in the Surgical Patient
Enthalten in Drugs Bd. 69, 29.9.2012, Nr. 1, date:11.2009: 29-32
|
|
|
|
110 |
Clinical Experience with Fortnightly Buprenorphine/Naloxone versus Buprenorphine in Italy
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 33-39
|
|
Administration
